Cytoxan

In the US, Cytoxan (cyclophosphamide systemic) is a member of the drug class alkylating agents and is used to treat Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Bladder Cancer, Brain Tumor, Breast Cancer, Bullous Pemphigoid, Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Cogan's Syndrome, Dermatomyositis, Endometrial Cancer, Ewing's Sarcoma, Histiocytosis, Hodgkin's Lymphoma, IgA Nephropathy, Multiple Myeloma, Multiple Sclerosis, Mycosis Fungoides, Nephrotic Syndrome, Neuroblastoma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Organ Transplant - Rejection Prophylaxis, Osteosarcoma, Ovarian Cancer, Pemphigoid, Pemphigus, Prostate Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Systemic Lupus Erythematosus, Systemic Sclerosis, Testicular Cancer, Wegener's Granulomatosus and Wilms' Tumor.

US matches:

• Cytoxan


• Cytoxan Tablets


• Cytoxan Lyophilized oral/injection


• Cytoxan oral/injection


• Cytoxan Lyophilized

Ingredient matches for Cytoxan

Cyclophosphamide

Cyclophosphamide is reported as an ingredient of Cytoxan in the following countries:

• Bulgaria


• Canada


• Colombia


• Philippines


• Serbia


• United States

Cyclophosphamide monohydrate (a derivative of Cyclophosphamide) is reported as an ingredient of Cytoxan in the following countries:

• Hungary

International Drug Name Search